To comprehensively investigate the development of recurrent bladder cancer and the PD-L1 overexpression resulting in tumor immune escape, we performed multi-omics experiments to delineate genetic, 5mC, and 5hmC alternations during the above processes. The gene discussed is CD274; the disease is urinary bladder carcinoma.